The People's Ledger
← All Illinois bills

HB3454Introduced in the House

EPINEPHRINE DELIVERY DEVICE

Passed

Introduced by Joyce Mason, District 61

What does this bill do?

Plain-English breakdown

Writing a plain-English summary of this bill… this can take a few seconds the first time.

Official description

Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

Where it stands

Public Act . . . . . . . . . 104-0762

August 7, 2026

How did lawmakers vote?

House votes

4 recorded votes · each counted separately

Senate votes

2 recorded votes · each counted separately

HouseStage: House Concurrence · May 31, 2026

116

Yes

0

No

1

Absent or Not Voting

117 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.

See how each representative voted

RepresentativeDistrictVote
Aaron Ortiz1Yes
Elizabeth Hernandez2Yes
Eva Dina Delgado3Yes
Lilian Jimenez4Yes
Kimberly Du Buclet5Yes
Sonya Harper6Yes
Emanuel Welch7Yes
LaShawn Ford8Yes
Yolanda Morris9Yes
Jawaharial Williams10Yes

Bill history

  1. Filed with the Clerk by Rep. Joyce Mason

  2. First Reading

  3. Referred to Rules Committee

  4. Assigned to Prescription Drug Affordability & Accessibility Committee

  5. Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000

  6. Placed on Calendar 2nd Reading - Short Debate

  7. Added Co-Sponsor Rep. Jawaharial Williams

  8. Added Co-Sponsor Rep. Harry Benton

  9. Added Co-Sponsor Rep. Dagmara Avelar

  10. Second Reading - Short Debate

  11. Held on Calendar Order of Second Reading - Short Debate

  12. Added Co-Sponsor Rep. Camille Y. Lilly

  13. Rule 19(a) / Re-referred to Rules Committee

  14. Added Chief Co-Sponsor Rep. Martha Deuter

  15. Approved for Consideration Rules Committee; 005-000-000

  16. Placed on Calendar 2nd Reading - Short Debate

  17. Placed on Calendar Order of 3rd Reading - Short Debate

  18. Third Reading - Short Debate - Passed 105-000-000

  19. Arrive in Senate

  20. Placed on Calendar Order of First Reading March 3, 2026

  21. Added Co-Sponsor Rep. Michelle Mussman

  22. Added Chief Co-Sponsor Rep. Janet Yang Rohr

  23. Chief Senate Sponsor Sen. Suzy Glowiak Hilton

  24. First Reading

  25. Referred to Assignments

  26. Assigned to Insurance

  27. Senate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton

  28. Senate Committee Amendment No. 1 Referred to Assignments

  29. Do Pass Insurance; 009-000-000

  30. Placed on Calendar Order of 2nd Reading May 7, 2026

  31. Second Reading

  32. Placed on Calendar Order of 3rd Reading May 18, 2026

  33. Senate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton

  34. Senate Floor Amendment No. 2 Referred to Assignments

  35. Senate Floor Amendment No. 2 Be Approved for Consideration Assignments

  36. Rule 2-10 Third Reading Deadline Established As May 31, 2026

  37. Recalled to Second Reading

  38. Senate Floor Amendment No. 2 Adopted; Glowiak-Hilton

  39. Placed on Calendar Order of 3rd Reading

  40. Third Reading - Passed; 059-000-000

  41. Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)

  42. Added as Alternate Co-Sponsor Sen. Mary Edly-Allen

  43. Arrived in House

  44. Placed on Calendar Order of Concurrence Senate Amendment(s) 2

  45. Senate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason

  46. Senate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee

  47. Added Chief Co-Sponsor Rep. Natalie A. Manley

  48. Senate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee

  49. Senate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000

  50. Senate Floor Amendment No. 2 House Concurs 116-000-000

  51. House Concurs

  52. Passed Both Houses

  53. Sent to the Governor

  54. Governor Approved

  55. Effective Date January 1, 2027

  56. Public Act . . . . . . . . . 104-0762

Verify the information

Our commitment to neutrality

We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.